These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1355417)

  • 21. Immunohistochemical studies show truncated dystrophins in the myotubes of three fetuses at risk for Duchenne muscular dystrophy.
    Ginjaar IB; Bakker E; van Paassen MM; den Dunnen JT; Wessels A; Zubrzycka-Gaarn EE; Moorman AF; van Ommen GJ
    J Med Genet; 1991 Aug; 28(8):505-10. PubMed ID: 1920366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy.
    Mirabella M; Servidei S; Manfredi G; Ricci E; Frustaci A; Bertini E; Rana M; Tonali P
    Neurology; 1993 Nov; 43(11):2342-5. PubMed ID: 8232953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Manifesting carriers of Duchenne muscular dystrophy over two generations].
    Itagaki Y; Saida K; Nishitani H; Matsuo M; Nishio H
    Rinsho Shinkeigaku; 1993 Apr; 33(4):377-81. PubMed ID: 8103723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A two-year-old clinically manifesting carrier of Duchenne muscular dystrophy].
    Yamamoto T; Kawahara H; Inagaki M; Ohta S
    No To Hattatsu; 1991 Jul; 23(4):384-8. PubMed ID: 1873056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy.
    Bushby KM; Goodship JA; Nicholson LV; Johnson MA; Haggerty ID; Gardner-Medwin D
    Neuromuscul Disord; 1993 Jan; 3(1):57-64. PubMed ID: 8329890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies.
    Sahashi K; Ibi T; Suoh H; Nakao N; Tashiro M; Marui K; Arahata K; Sugita H
    Intern Med; 1994 May; 33(5):277-83. PubMed ID: 7949630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germinal mosaicism in a Duchenne muscular dystrophy family: implications for genetic counselling.
    Melis MA; Cau M; Congiu R; Puddu R; Muntoni F; Cao A
    Clin Genet; 1993 May; 43(5):247-9. PubMed ID: 8375105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dystrophin immunofluorescence pattern in manifesting and asymptomatic carriers of Duchenne's and Becker muscular dystrophies of different ages.
    Vainzof M; Pavanello RC; Pavanello I; Tsanaclis AM; Levy JA; Passos-Bueno MR; Rapaport D; Zatz M
    Neuromuscul Disord; 1991; 1(3):177-83. PubMed ID: 1822792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The "rescue" of dystrophin synthesis in boys with Duchenne muscular dystrophy.
    Nicholson LV
    Neuromuscul Disord; 1993; 3(5-6):525-31. PubMed ID: 8186705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of PCR-deletion detection and immunohistochemistry in Brazilian Duchenne and Becker muscular dystrophy patients.
    Werneck LC; Scola RH; Maegawa GH; Werneck MC
    Am J Med Genet; 2001 Oct; 103(2):115-20. PubMed ID: 11568916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A carrier of Duchenne muscular dystrophy with dilated cardiomyopathy but no skeletal muscle symptom.
    Kinoshita H; Goto Y; Ishikawa M; Uemura T; Matsumoto K; Hayashi YK; Arahata K; Nonaka I
    Brain Dev; 1995; 17(3):202-5. PubMed ID: 7573761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T; Stuettgen P; Cremer M; Goebel HH
    Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dystrophin immunocytochemistry in muscle culture: detection of a carrier of Duchenne muscular dystrophy.
    Miranda AF; Francke U; Bonilla E; Martucci G; Schmidt B; Salviati G; Rubin M
    Am J Med Genet; 1989 Feb; 32(2):268-73. PubMed ID: 2648829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface.
    Bonilla E; Samitt CE; Miranda AF; Hays AP; Salviati G; DiMauro S; Kunkel LM; Hoffman EP; Rowland LP
    Cell; 1988 Aug; 54(4):447-52. PubMed ID: 3042151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A symptomatic female patient with Duchenne muscular dystrophy diagnosed by dystrophin-staining: a case report.
    Shigihara-Yasuda K; Tonoki H; Goto Y; Arahata K; Ishikawa N; Kajii N; Fujieda K
    Eur J Pediatr; 1992 Jan; 151(1):66-8. PubMed ID: 1370218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A model to estimate the expression of the dystrophin gene in muscle from female Becker muscular dystrophy carriers.
    Vainzof M; Passos-Bueno MR; Pavanello RC; Schreiber R; Zatz M
    J Med Genet; 1992 Jul; 29(7):476-9. PubMed ID: 1640426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular pathology of Duchenne and Becker muscular dystrophy].
    Sugita H
    Rinsho Shinkeigaku; 1990 Dec; 30(12):1309-16. PubMed ID: 2099874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA analysis of Duchenne and Becker muscular dystrophy using pERT87 genomic probes and dystrophin cDNA probes--establishing the optimum strategy for carrier diagnosis in the Japanese population.
    Ubagai T; Katayama S
    Jinrui Idengaku Zasshi; 1991 Sep; 36(3):211-27. PubMed ID: 1684391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of DMD carrier status in a family with no known affected males.
    Muntoni F; Mateddu A; Cau M; Congiu R; Puddu R; Cossu P; Cao A; Melis MA
    Dev Med Child Neurol; 1993 Jan; 35(1):70-3. PubMed ID: 8095479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
    Sundaram C; Vydehi B; Meena K; Murthy J
    Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.